GLYC logo

GlycoMimetics (GLYC) Cash From Operations

Annual CFO

-$34.88 M
+$11.58 M+24.92%

December 31, 2023


Summary


Performance

GLYC Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLYCcash flowmetrics:

Quarterly CFO

-$7.99 M
+$899.00 K+10.11%

September 30, 2024


Summary


Performance

GLYC Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLYCcash flowmetrics:

TTM CFO

-$35.01 M
+$688.80 K+1.93%

September 30, 2024


Summary


Performance

GLYC TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLYCcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

GLYC Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.9%-5.0%-0.4%
3 y3 years+11.1%+37.6%+39.1%
5 y5 years+19.5%+37.6%+39.1%

GLYC Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+39.3%-14.6%+50.8%-3.6%+41.3%
5 y5-yearat high+39.3%-128.4%+52.8%-3.6%+41.3%
alltimeall time-351.8%+39.3%-158.9%+52.8%-1403.7%+41.3%

GlycoMimetics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.99 M(-10.1%)
-$35.01 M(-1.9%)
Jun 2024
-
-$8.89 M(-15.4%)
-$35.70 M(+5.7%)
Mar 2024
-
-$10.51 M(+38.0%)
-$33.78 M(-3.1%)
Dec 2023
-$34.88 M(-24.9%)
-$7.62 M(-12.3%)
-$34.88 M(-0.8%)
Sep 2023
-
-$8.68 M(+24.5%)
-$35.18 M(+0.2%)
Jun 2023
-
-$6.97 M(-39.9%)
-$35.11 M(-20.9%)
Mar 2023
-
-$11.61 M(+46.7%)
-$44.37 M(-4.5%)
Dec 2022
-$46.46 M(-19.2%)
-$7.91 M(-8.2%)
-$46.46 M(-9.5%)
Sep 2022
-
-$8.62 M(-46.9%)
-$51.35 M(-14.0%)
Jun 2022
-
-$16.23 M(+18.5%)
-$59.68 M(+4.6%)
Mar 2022
-
-$13.70 M(+7.0%)
-$57.06 M(-0.7%)
Dec 2021
-$57.49 M(+46.5%)
-$12.81 M(-24.4%)
-$57.49 M(+5.7%)
Sep 2021
-
-$16.95 M(+24.5%)
-$54.37 M(+11.1%)
Jun 2021
-
-$13.61 M(-3.6%)
-$48.93 M(-1.9%)
Mar 2021
-
-$14.13 M(+45.8%)
-$49.87 M(+27.1%)
Dec 2020
-$39.24 M(-24.5%)
-$9.69 M(-15.8%)
-$39.24 M(-7.3%)
Sep 2020
-
-$11.50 M(-20.9%)
-$42.35 M(-4.4%)
Jun 2020
-
-$14.55 M(+315.8%)
-$44.29 M(+7.7%)
Mar 2020
-
-$3.50 M(-72.6%)
-$41.14 M(-20.9%)
Dec 2019
-$51.98 M(+20.0%)
-$12.79 M(-4.9%)
-$51.98 M(+5.7%)
Sep 2019
-
-$13.45 M(+18.0%)
-$49.17 M(+7.3%)
Jun 2019
-
-$11.39 M(-20.6%)
-$45.81 M(-3.5%)
Mar 2019
-
-$14.35 M(+43.8%)
-$47.47 M(+9.6%)
Dec 2018
-$43.33 M
-$9.98 M(-1.0%)
-$43.33 M(+3.9%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$10.08 M(-22.8%)
-$41.72 M(+10.2%)
Jun 2018
-
-$13.06 M(+27.9%)
-$37.87 M(+22.5%)
Mar 2018
-
-$10.21 M(+22.0%)
-$30.92 M(+3.9%)
Dec 2017
-$29.77 M(+0.1%)
-$8.37 M(+34.3%)
-$29.77 M(+8.8%)
Sep 2017
-
-$6.23 M(+2.0%)
-$27.35 M(-4.3%)
Jun 2017
-
-$6.11 M(-32.6%)
-$28.60 M(-3.3%)
Mar 2017
-
-$9.06 M(+52.2%)
-$29.56 M(-0.6%)
Dec 2016
-$29.73 M(+260.7%)
-$5.95 M(-20.3%)
-$29.73 M(-3.3%)
Sep 2016
-
-$7.47 M(+5.6%)
-$30.73 M(+216.9%)
Jun 2016
-
-$7.08 M(-23.3%)
-$9.70 M(+10.6%)
Mar 2016
-
-$9.23 M(+32.7%)
-$8.77 M(+6.4%)
Dec 2015
-$8.24 M(+92.5%)
-$6.96 M(-151.3%)
-$8.24 M(+10.8%)
Sep 2015
-
$13.56 M(-320.8%)
-$7.44 M(-71.1%)
Jun 2015
-
-$6.14 M(-29.4%)
-$25.76 M(+147.7%)
Mar 2015
-
-$8.71 M(+41.4%)
-$10.40 M(+142.9%)
Dec 2014
-$4.28 M(-72.4%)
-$6.15 M(+29.5%)
-$4.28 M(+15.9%)
Sep 2014
-
-$4.75 M(-151.6%)
-$3.69 M(+58.6%)
Jun 2014
-
$9.21 M(-456.1%)
-$2.33 M(-83.7%)
Mar 2014
-
-$2.59 M(-53.5%)
-$14.25 M(-8.3%)
Dec 2013
-$15.54 M(+48.4%)
-$5.57 M(+64.2%)
-$15.54 M(+55.8%)
Sep 2013
-
-$3.39 M(+25.2%)
-$9.97 M(+51.5%)
Jun 2013
-
-$2.71 M(-30.2%)
-$6.58 M(+69.8%)
Mar 2013
-
-$3.88 M
-$3.88 M
Dec 2012
-$10.47 M(-175.6%)
-
-
Dec 2011
$13.85 M
-
-

FAQ

  • What is GlycoMimetics annual cash flow from operations?
  • What is the all time high annual CFO for GlycoMimetics?
  • What is GlycoMimetics annual CFO year-on-year change?
  • What is GlycoMimetics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for GlycoMimetics?
  • What is GlycoMimetics quarterly CFO year-on-year change?
  • What is GlycoMimetics TTM cash flow from operations?
  • What is the all time high TTM CFO for GlycoMimetics?
  • What is GlycoMimetics TTM CFO year-on-year change?

What is GlycoMimetics annual cash flow from operations?

The current annual CFO of GLYC is -$34.88 M

What is the all time high annual CFO for GlycoMimetics?

GlycoMimetics all-time high annual cash flow from operations is $13.85 M

What is GlycoMimetics annual CFO year-on-year change?

Over the past year, GLYC annual cash flow from operations has changed by +$11.58 M (+24.92%)

What is GlycoMimetics quarterly cash flow from operations?

The current quarterly CFO of GLYC is -$7.99 M

What is the all time high quarterly CFO for GlycoMimetics?

GlycoMimetics all-time high quarterly cash flow from operations is $13.56 M

What is GlycoMimetics quarterly CFO year-on-year change?

Over the past year, GLYC quarterly cash flow from operations has changed by -$379.40 K (-4.98%)

What is GlycoMimetics TTM cash flow from operations?

The current TTM CFO of GLYC is -$35.01 M

What is the all time high TTM CFO for GlycoMimetics?

GlycoMimetics all-time high TTM cash flow from operations is -$2.33 M

What is GlycoMimetics TTM CFO year-on-year change?

Over the past year, GLYC TTM cash flow from operations has changed by -$131.60 K (-0.38%)